J&J unit and Gilead's combo HIV pill Complera gets FDA OK

08/10/2011 | Forbes

The FDA approved Complera, an oral HIV drug containing Truvada, from Gilead Sciences, and Edurant, from Johnson & Johnson unit Tibotec. Complera is indicated for once-daily use by previously untreated patients.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care